LYON, France & NEW YORK--(BUSINESS WIRE)--The MEDICREA group (Paris:ALMED) (Alternext Paris: FR0004178572 - ALMED), a PEA-PME eligible company specializing in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, pursuant to the authorization granted by the Extraordinary Shareholders Meeting of June 3rd, 2015, announces the successful completion of a capital increase of 3.5 million euros (share premium included) via a private placement. T